Indoco Remedies zooms on launching Brinzolamide Ophthalmic Suspension 1% in United States

09 Mar 2021 Evaluate

Indoco Remedies is currently trading at Rs. 290.65, up by 14.05 points or 5.08% from its previous closing of Rs. 276.60 on the BSE.

The scrip opened at Rs. 276.75 and has touched a high and low of Rs. 294.75 and Rs. 276.75 respectively. So far 9923 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 335.55 on 19-Jan-2021 and a 52 week low of Rs. 145.50 on 23-Mar-2020.

Last one week high and low of the scrip stood at Rs. 297.90 and Rs. 275.30 respectively. The current market cap of the company is Rs. 2658.08 crore.

The promoters holding in the company stood at 58.69 % while Institutions and Non-Institutions held 19.99 % and 21.32 % respectively.

Indoco Remedies has launched Brinzolamide Ophthalmic Suspension 1% in the United States, the first generic version of AZOPT by Teva Pharmaceuticals. The product is developed and manufactured by Indoco Remedies for TEVA at its facility in Goa.

The ANDA approved by the US Food and Drug Administration for Brinzolamide Ophthalmic Suspension 1%, is used to treat high pressure inside the eye due to ocular hypertension and open-angle glaucoma. Brinzolamide Ophthalmic Suspension 1% works by decreasing the amount of fluid within the eye.The US market size of this product is $184 million, according to IQVIA data as of December, 2020.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

251.25 -0.65 (-0.26%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×